Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Contineum Therapeutics (CTNM)

Annual Return

Since Apr 5, 2024, CTNM has had an average annual return of -4.37%, underperforming the benchmark SPY, which returned +18.72% annual.

202620252024
+21.61%-21.98%-4.87%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+24.76%+7.57%-14.86%-1.84%+5.23%+21.50%-15.19%+21.61%
2025-33.18%-28.10%-0.85%-41.11%-10.94%+8.46%+48.60%+77.13%+12.44%-6.30%+0.55%+3.26%-21.98%
2024+1.30%-1.80%+14.95%+13.91%-2.84%-1.79%-12.44%-11.04%-1.75%-4.87%

Drawdown analysis of Contineum Therapeutics (CTNM)

The maximum drawdown for the CTNM was -84.37%, occurring on May 28, 2025. This drawdown has not yet recovered.

The current CTNM drawdown is -36.09%.

Since Apr 5, 2024 CTNM has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-84.37%Jul 16, 2024217May 28, 2025OngoingOngoingOngoing
-15.33%Jun 26, 20242Jun 28, 20241Jul 1, 20243
-11.94%Apr 29, 20244May 3, 20244May 9, 20248
-10.99%Jun 10, 20241Jun 11, 20245Jun 18, 20246
-8.76%May 23, 20242May 28, 20247Jun 6, 20249
-8.23%Apr 11, 20242Apr 15, 20247Apr 24, 20249
-6.62%May 9, 20245May 16, 20245May 23, 202410
-5.54%Jun 20, 20241Jun 21, 20242Jun 25, 20243
-4.62%Jul 1, 20243Jul 5, 20243Jul 10, 20246
-4.22%Apr 5, 20243Apr 10, 20241Apr 11, 20244
-1.69%Apr 25, 20241Apr 26, 20241Apr 29, 20242
-1.37%Jul 10, 20242Jul 12, 20242Jul 16, 20244